Psychology; definitions; prescriptions; criteria; certification; licensed psychologists; immunity; prescription certificate; rules; effective date.
HB1173 would create a new framework in Oklahoma law allowing licensed psychologists to prescribe psychotropic medications if they obtain a state-issued prescription certificate. The bill defines key terms such as “conditional prescription certificate,” “prescription certificate,” “psychotropic medication,” and “supervising physician,” and it distinguishes between supervised prescribing and independent prescribing. Under the proposal, a psychologist with a conditional certificate could prescribe psychotropic drugs only under physician supervision, while a psychologist with a full prescription certificate could prescribe independently.
To qualify for a conditional prescription certificate, an applicant must already hold an Oklahoma psychology license and complete substantial additional training in psychopharmacology, including an approved postdoctoral master’s degree, a national certification exam, and either a 450-hour classroom-based educational program or a supervised clinical practicum involving at least 400 hours and treatment of at least 100 patients. The certificate would be issued by the State Board of Examiners of Psychologists, last two years, and be renewable through reapplication. The bill also requires malpractice insurance, notice to the board of the supervising physician, and notice by the supervising physician to their licensing board.
The bill’s impact would be to expand the scope of practice for psychologists in Oklahoma and create a new regulatory and credentialing system within Title 59 of the Oklahoma Statutes. It would also involve the State Board of Examiners of Psychologists, the State Board of Medical Licensure and Supervision, and the State Board of Osteopathic Examiners in approving education, examinations, and supervised clinical training. In addition, the bill provides limited liability protection for supervising physicians, stating they are not liable for a psychologist’s acts unless the injury or loss arose from acts under the physician’s direction and control.
The general sentiment reflected in the available voting history appears cautiously favorable, at least at the committee level. HB1173 received a 4-2 “Do Pass” vote in the House Public Health Committee and was advanced as a policy recommendation to the Health and Human Services Oversight committee. No committee transcript was provided, so there is no recorded debate to indicate broader support or opposition beyond the vote itself.
The main point of contention is likely the expansion of prescribing authority to psychologists, especially the question of whether non-physicians should be authorized to prescribe psychotropic drugs and under what level of supervision. The bill’s detailed training requirements suggest an effort to address safety and competency concerns, while the supervision and immunity provisions indicate attention to physician oversight and liability. Potential stakeholders include psychologists seeking expanded practice authority, physicians and medical boards concerned with prescribing oversight, and patients receiving mental health treatment.
HB1173 would amend Oklahoma law by adding new provisions to Title 59 governing psychologist prescribing authority, creating a certification process for psychotropic prescribing, and assigning rulemaking and approval roles to the psychology, medical, and osteopathic boards. It would expand the scope of practice for licensed psychologists, establish supervised and independent prescribing pathways, and create related notice, insurance, and liability rules affecting psychologists, supervising physicians, and the state licensing boards.
The available legislative history shows a generally favorable committee response, with the House Public Health Committee voting 4-2 to advance the bill. That suggests support for exploring psychologist prescribing authority, though the close vote indicates some hesitation or concern. No transcript is available, so the broader discussion cannot be assessed beyond the committee vote and the bill’s detailed safeguards.
The likely controversy centers on whether psychologists should be allowed to prescribe psychotropic medications at all, and if so, whether the training and supervision requirements are sufficient to protect patient safety. Supporters would likely emphasize expanded access to mental health treatment and a structured credentialing process, while opponents may focus on scope-of-practice concerns, medical oversight, and liability. The bill’s requirement for physician supervision during the conditional phase and its limited immunity for supervising physicians appear designed to address those concerns.